CIK 0000897448 · Accelerated filer
AMARIN CORP PLCUK
Sign in to watch- Ticker
- AMRN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 353 1 6699 020
- Business address
- SPACES SOUTH DOCKLANDS, BLOCK C, 77 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, Ireland
- Former names
- AMARIN CORP PLC\UK, AMARIN PHARMACEUTICALS PLC, ETHICAL HOLDINGS PLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-26 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −6,736 | 40,416 | ||
| 2021-02-26 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −6,736 | 40,416 | ||
| 2021-02-26 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −13,472 | 80,832 | ||
| 2021-02-26 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −59,367 | 118,733 | ||
| 2021-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise | +88,614 | 315,714 | ||
| 2021-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Shares withheld for taxes | −43,638 | $7.30 | $319K | 272,076 |
| 2021-02-25 | Berg Aaron CHIEF COMMERCIAL OFFICER | Option exercise · Restricted Stock Units | −88,614 | 21,386 | ||
| 2021-02-25 | Kalb Michael Wayne SVP and CFO | Option exercise | +88,614 | 218,924 | ||
| 2021-02-25 | Kalb Michael Wayne SVP and CFO | Shares withheld for taxes | −43,395 | $7.30 | $317K | 175,529 |
| 2021-02-25 | Kalb Michael Wayne SVP and CFO | Option exercise · Restricted Stock Units | −88,614 | 21,386 | ||
| 2021-02-25 | Ketchum Steven B Chief Scientific Officer | Option exercise | +88,614 | 471,610 | ||
| 2021-02-25 | Ketchum Steven B Chief Scientific Officer | Shares withheld for taxes | −45,327 | $7.30 | $331K | 426,283 |
| 2021-02-25 | Ketchum Steven B Chief Scientific Officer | Option exercise · Restricted Stock Units | −88,614 | 21,386 | ||
| 2021-02-25 | Kennedy Joseph T General Counsel | Option exercise | +104,728 | 344,761 | ||
| 2021-02-25 | Kennedy Joseph T General Counsel | Shares withheld for taxes | −55,140 | $7.30 | $403K | 289,621 |
| 2021-02-25 | Kennedy Joseph T General Counsel | Option exercise · Restricted Stock Units | −104,728 | 25,272 | ||
| 2021-02-25 | THERO JOHN F President and CEO | Option exercise | +390,696 | 3,272,445 | ||
| 2021-02-25 | THERO JOHN F President and CEO | Shares withheld for taxes | −153,739 | $7.30 | $1.1M | 3,118,706 |
| 2021-02-25 | THERO JOHN F President and CEO | Option exercise · Restricted Stock Units | −390,696 | 94,304 | ||
| 2021-02-01 | Ketchum Steven B Chief Scientific Officer | Option exercise | +16,703 | $2.50 | $42K | 425,069 |
Page 36 of 67 · 1,339 trades